Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CELF4 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | ZNF302 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | KCNC1 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
mRNA | IGFBPL1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | CDH24 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | DOK2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | ZNF516 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | TSNARE1 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | LDOC1L | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
mRNA | PLPPR3 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |